Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec;20(6):255.
doi: 10.3892/etm.2020.9385. Epub 2020 Oct 23.

MicroRNA-208a-3p promotes osteosarcoma progression via targeting PTEN

Affiliations

MicroRNA-208a-3p promotes osteosarcoma progression via targeting PTEN

Yutuo Fu et al. Exp Ther Med. 2020 Dec.

Abstract

Osteosarcoma (OS) is a malignant bone tumor with a poor prognosis. Accumulated evidence has suggested that microRNAs (miRNAs/miRs) may function as either oncogenes or tumor suppressors, which are associated with tumorigenesis and the progression of different types of cancer. In the present study, the role of miR-208a-3p in OS was investigated. The expression levels of miR-208a-3p in OS tissues and cell lines were determined via reverse transcription-quantitative PCR (RT-qPCR). MTT and colony formation assays were performed to verify the proliferation rate of OS cells. In addition, the effects of miR-208a-3p on the migration and invasion of OS cells were revealed using wound-healing and Transwell assays, respectively. Furthermore, the association between miR-208a-3p and phosphatase and tensin homolog (PTEN) 3'-untranslated region was determined via luciferase reporter assays, western blot and RT-qPCR analysis. The results indicated that miR-208a-3p was upregulated in OS tissues and cell lines compared with adjacent normal tissues and human osteoblastic cells, respectively. miR-208a-3p overexpression promoted and miR-208a-3p knockdown inhibited OS cells proliferation and metastatic potential. Additionally, PTEN was validated as a direct target of miR-208a-3p and its expression was negatively associate with that of miR-208a-3p in OS cells. Taken together, these results may suggest that miR-208a-3p promoted OS cells proliferation and metastatic potential via targeting PTEN. Therefore, miR-208a-3p may be considered as a diagnostic biomarker for OS.

Keywords: invasion; microRNA-208a-3p; migration; osteosarcoma; phosphatase and tensin homolog; proliferation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Expression of miR-208a-3p in OS tissues and cell lines. (A) RT-qPCR analysis of miR-208a-3p expression levels in 10 pairs of OS tissues and adjacent normal tissues. (B) RT-qPCR was performed to detect the expression levels of miR-208a-3p in osteoblast cells (hFOB 1.19) and OS cell lines SaOS-2, U2OS and MG-63. **P<0.01 and ***P<0.001. RT-qPCR, reverse transcription-quantitative PCR; miR, microRNA; CTL, control; OS, osteosarcoma.
Figure 2
Figure 2
Overexpression of miR-208a-3p promotes proliferation in osteosarcoma cells. (A) The proliferation of SaOS-2, U2OS and MG-63 cells following overexpression of miR-208a-3p was determined via MTT assays at different time points. (B) Colony formation assays were performed to detect the proliferation of SaOS-2, U2OS and MG-63 cells following overexpression of miR-208a-3p. *P<0.05, **P<0.01 and ***P<0.001 vs. mimic NC. NC, negative control; miR, microRNA; OD, optical density.
Figure 3
Figure 3
Overexpression of miR-208a-3p facilitates osteosarcoma cell invasion and migration. (A) The invasion of SaOS-2, U2OS and MG-63 cells following overexpression of miR-208a-3p was detected via Transwell assays (magnification, x100). (B) The migration of SaOS-2, U2OS and MG-63 cells following overexpression of miR-208a-3p was examined via wound-healing assays (magnification, x40). NC, negative control; miR, microRNA.
Figure 4
Figure 4
Knockdown of miR-208a-3p inhibits osteosarcoma cell proliferation. (A) MTT assays were performed to detect the proliferation of SaOS-2, U2OS and MG-63 cells following knockdown of miR-208a-3p at different time points. (B) The proliferation of SaOS-2, U2OS and MG-63 cells following knockdown of miR-208a-3p was examined via colony formation assays. *P<0.05, **P<0.01 and ***P<0.001 vs. inhibitor NC. NC, negative control; miR, microRNA; OD, optical density.
Figure 5
Figure 5
Knockdown of miR-208a-3p suppresses the invasion and migration of OS cells. (A) Transwell assays were performed to detect the invasion of OS cells following knockdown of miR-208a-3p (magnification, x100). (B) Wound healing assays were performed to detect the migration of OS cells following knockdown of miR-208a-3p (magnification, x40). NC, negative control; miR, microRNA; OS, osteosarcoma.
Figure 6
Figure 6
PTEN is a direct target of miR-208a-3p. (A) Potential binding site between miR-208a-3p and the 3'-UTR of PTEN. (B) A luciferase reporter assay was conducted to verify that PTEN was directly targeted by miR-208a-3p. ***P<0.001. (C) The mRNA expression levels of PTEN in OS cells was detected via reverse transcription-quantitative PCR. *P<0.05. (D) Western blotting was performed to measure the protein expression levels of PTEN in OS cells. **P<0.01 and ***P<0.001 vs. NC groups. UTR, untranslated region; NC, negative control; miR, microRNA; OS, osteosarcoma; wt, wild-type; mut, mutant.

Similar articles

Cited by

References

    1. Bielack S, Carrle D, Casali PG. Osteosarcoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2009;20 (Suppl 4):137–139. doi: 10.1093/annonc/mdp154. ESMO Guidelines Working Group. - DOI - PubMed
    1. Camuzard O, Santucci-Darmanin S, Carle GF, Pierrefite-Carle V. Role of autophagy in osteosarcoma. J Bone Oncol. 2019;16(100235) doi: 10.1016/j.jbo.2019.100235. - DOI - PMC - PubMed
    1. Yao Z, Han L, Chen Y, He F, Sun B, Kamar S, Zhang Y, Yang Y, Wang C, Yang Z. Hedgehog signalling in the tumourigenesis and metastasis of osteosarcoma, and its potential value in the clinical therapy of osteosarcoma. Cell Death Dis. 2018;9(701) doi: 10.1038/s41419-018-0647-1. - DOI - PMC - PubMed
    1. Sasaki R, Osaki M, Okada F. MicroRNA-Based Diagnosis and Treatment of Metastatic Human Osteosarcoma. Cancers (Basel) 2019;11(11) doi: 10.3390/cancers11040553. - DOI - PMC - PubMed
    1. Anninga JK, Gelderblom H, Fiocco M, Kroep JR, Taminiau AH, Hogendoorn PC, Egeler RM. Chemotherapeutic adjuvant treatment for osteosarcoma: Where do we stand? Eur J Cancer. 2011;47:2431–2445. doi: 10.1016/j.ejca.2011.05.030. - DOI - PubMed